Teva to Double Production Capacity in Japan

Israeli pharma giant looking to Japan as an entry point to the lucrative markets of China and Southeast Asia.

comments Print
Teva Pharmaceutical Industries Ltd, the world's biggest maker of generic medicines, will spend about 20 billion yen ($203 million) to double its production capacity in Japan as the country looks to contain its...